Article
Comparison of EGFR and K-RAS gene status between primary tumours and corresponding metastases in NSCLC.
British journal of cancer - 16 Sept 2008
Kalikaki A, Koutsopoulos A, Trypaki M, Souglakos J, Stathopoulos E, Georgoulias V, Mavroudis D, Voutsina A
Abstract excerpt
In non-small-cell lung cancer (NSCLC), epidermal growth factor receptor (EGFR) and K-RAS mutations of the primary tumour are associated with responsiveness and resistance to tyrosine kinase inhibitors (TKIs), respectively. However, the EGFR and K-RAS mutation status in metastases is not well studied. We compared the mutation status of these genes between the primary tumours and the corresponding metastases of 25...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.